- Open
- 9.00
- High
- 9.50
- Low
- 8.50
- Close
- 9.50
- Change
- +0.00 (0.00%)
- Volume
- 16,204
| 16 Nov 2026 | 07:00:08 | MoU signed with Centre for Process Innovation |
| 11 Nov 2026 | 10:13:54 | Notice of AGM & availability of 2026 Annual Report |
| 13 Oct 2026 | 07:00:03 | Final Results |
| 7 Oct 2026 | 07:00:04 | Notice of Results |
| 28 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 6 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 27 Oct 2023 | Annual Report and Accounts (to 2023-06-30) |
Abingdon Health plc develops, manufactures, and distributes diagnostic devices, focusing on rapid tests and lateral flow tests. The company also provides regulatory consultancy services to businesses in the diagnostics sector. Its customer base includes healthcare providers and organizations in various markets, and it operates primarily in the diagnostics industry. Abingdon Health is involved in research and development to enhance its product offerings and sustainability initiatives.
| 16 Nov 2026 | 07:00:08 | MoU signed with Centre for Process Innovation |
| 11 Nov 2026 | 10:13:54 | Notice of AGM & availability of 2026 Annual Report |
| 13 Oct 2026 | 07:00:03 | Final Results |
| 7 Oct 2026 | 07:00:04 | Notice of Results |
| 28 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 6 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 27 Oct 2023 | Annual Report and Accounts (to 2023-06-30) |
Abingdon Health plc develops, manufactures, and distributes diagnostic devices, focusing on rapid tests and lateral flow tests. The company also provides regulatory consultancy services to businesses in the diagnostics sector. Its customer base includes healthcare providers and organizations in various markets, and it operates primarily in the diagnostics industry. Abingdon Health is involved in research and development to enhance its product offerings and sustainability initiatives.
| 29 Sept 2026 |
| 07:00:08 |
| UKAS ISO/IEC 17025 accreditation |
| 5 May 2026 |
| AIM Market Roundup: Abingdon Health, Autins, IQE |
| 20 Apr 2026 | AIM Market Roundup: Clean Power Hydrogen, Abingdon Health, AMS |
| 2 Apr 2026 | Abingdon Health chair on H1 performance, new contracts, OTC admission, and the path ahead |
| 30 Mar 2026 | AIM movers: Abingdon Health wins US contracts and Mirriad Advertising running out of cash |
| 30 Mar 2026 | Abingdon Health up 14% after it wins £4.8m of US contracts for multiplex diagnostic test development |
| 12 Mar 2026 | AIM movers: Restore upgrade and ex-dividends |
| 29 Sept 2026 |
| 07:00:08 |
| UKAS ISO/IEC 17025 accreditation |
| 5 May 2026 |
| AIM Market Roundup: Abingdon Health, Autins, IQE |
| 20 Apr 2026 | AIM Market Roundup: Clean Power Hydrogen, Abingdon Health, AMS |
| 2 Apr 2026 | Abingdon Health chair on H1 performance, new contracts, OTC admission, and the path ahead |
| 30 Mar 2026 | AIM movers: Abingdon Health wins US contracts and Mirriad Advertising running out of cash |
| 30 Mar 2026 | Abingdon Health up 14% after it wins £4.8m of US contracts for multiplex diagnostic test development |
| 12 Mar 2026 | AIM movers: Restore upgrade and ex-dividends |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £997m | +0.1% | |
| £27m | -0.0% | |
ABDXAbingdon Health plc | £24m | +0.1% |
| £14m | +0.2% | |
| £5m | -0.4% | |
| £3m | -0.4% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £997m | +0.1% | |
| £27m | -0.0% | |
ABDXAbingdon Health plc | £24m | +0.1% |
| £14m | +0.2% | |
| £5m | -0.4% | |
| £3m | -0.4% |